Shotlee LogoShotlee
Blog
Download on theApp Store
Get it onGoogle Play
Skip to main content
New Data: Little Weight Rebound After Stopping Ozempic, Wegovy - Featured image
GLP-1 Medications

New Data: Little Weight Rebound After Stopping Ozempic, Wegovy

Dr. Adrian Vale, MD
Reviewed by Dr. Adrian Vale, MDInternal Medicine · Board-Certified Obesity Medicine
·January 23, 2026·1 min read

Track Smart

Calculate active GLP-1 levels automatically with Shotlee.

Download →

New research challenges fears of quick weight regain after stopping GLP-1 drugs like Ozempic and Wegovy. Real-world data reveals many patients sustain their losses. Experts say durability is possible without lifelong treatment.

Share

New research suggests that many people who stop using GLP-1 drugs like Ozempic maintain their weight loss, countering previous studies.

Real-World Insights Challenge Clinical Trial Findings

Many patients using highly effective GLP-1 drugs may not regain lost weight quickly when they stop treatment. This comes from an analysis of real-world data addressing a key concern about these therapies.

Precision tracking for your journey

Join thousands using Shotlee to accurately track GLP-1 medications and side effects.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store
Get it onGoogle Play

The data contradicts findings from Novo Nordisk's clinical trials, which warned that many patients regain weight soon after interrupting treatment.

Expert Views on Long-Term Use

Obesity specialists have questioned whether people need these medicines for years to keep benefits.

"The implication of our real-world evidence is not that rebound risk is negligible, but rather that durability is achievable in routine care," said Nference chief scientific officer Venky Soundararajan.

Source Information

Originally published by South China Morning Post.Read the original article →

Read next

Keep exploring

More on Ozempic

Articles covering Ozempic dosing, side effects, and clinical updates.

Ozempic and Male Fertility: Can Semaglutide Boost Sperm Quality?
Health & Wellness

Ozempic and Male Fertility: Can Semaglutide Boost Sperm Quality?

Emerging research indicates that GLP-1 medications, including Ozempic and Mounjaro, may offer unexpected benefits for male reproductive health by addressing underlying metabolic issues.

7 min read
Semaglutide and Male Fertility: New Study Reveals Testosterone Boost
Health & Wellness

Semaglutide and Male Fertility: New Study Reveals Testosterone Boost

Can GLP-1 medications like Ozempic or Wegovy improve male fertility? A new study indicates potential benefits for testosterone and sperm health, but what does this mean for patients?

7 min read
Semaglutide and Blood Pressure Meds: Why Dizziness Risk Is Rising
Health & Wellness

Semaglutide and Blood Pressure Meds: Why Dizziness Risk Is Rising

A new study reveals a potential safety concern when combining GLP-1 medications with blood pressure drugs, highlighting the importance of monitoring hypotensive episodes in select patients.

8 min read

Same topic: Ozempic

All Ozempic articles →
How to Keep Weight Off After Ozempic: Proven Strategies
GLP-1 Medications

How to Keep Weight Off After Ozempic: Proven Strategies

Stopping Ozempic often leads to weight regain—up to 7% in trials or two-thirds within a year. While continuing semaglutide helps sustain losses, lifestyle changes and maintenance dosing offer alternatives. Work with your healthcare team for a personalized plan to keep the weight off long-term.

6 min read
Ozempic Fuels Tapatío Hot Sauce Boom: L.A. Icon's Story
GLP-1 Medications

Ozempic Fuels Tapatío Hot Sauce Boom: L.A. Icon's Story

Ozempic isn't just transforming waistlines—it's igniting a surge in hot sauce sales like Tapatío's. As millions embrace GLP-1 drugs, cravings for bold flavors skyrocket, propelling L.A.'s iconic brand into national expansion under new owners Highlander Partners. This is the untold story of family legacy meeting metabolic health trends.

5 min read
Taking GLP-1s? Doctors Stress Movement and Mental Health Too
GLP-1 Medications

Taking GLP-1s? Doctors Stress Movement and Mental Health Too

Jelon Smart from Savannah dropped 110 pounds on Ozempic—but credits her intensive workout regimen too. Facing severe ankle swelling from Achilles tendinitis at 285 pounds, she transformed her life. Doctors remind GLP-1 users: movement and mental health are essential alongside medication.

5 min read

More in GLP-1 Medications

Wegovy, Zepbound & More: Hers Makes GLP-1s Accessible from $39
Health & Wellness

Wegovy, Zepbound & More: Hers Makes GLP-1s Accessible from $39

The journey to weight loss can be challenging, and for many, advanced medications like GLP-1 injectables offer a crucial pathway. However, their high cost often presents a significant barrier. Hers is changing this landscape by making popular GLP-1 and other weight loss treatments more accessible and affordable than ever before.

7 min read
Beyond GLP-1s: Unlocking Better Diabetes Control with Korlym
Medical Insights

Beyond GLP-1s: Unlocking Better Diabetes Control with Korlym

For individuals struggling with difficult-to-control type 2 diabetes and weight management, even powerful GLP-1 medications might not be enough. New research highlights the significant role of hypercortisolism and the promising potential of Korlym in optimizing treatment outcomes.

6 min read
Beyond the Needle: New Oral Semaglutide Tech Could Change Weight Loss Forever
Medical Innovation

Beyond the Needle: New Oral Semaglutide Tech Could Change Weight Loss Forever

Duke University researchers have developed a novel oral delivery system for GLP-1 medications that protects peptides from stomach acid, potentially eliminating the need for injections.

8 min read
Share this article
  1. Home
  2. Blog
  3. New Data: Little Weight Rebound After Stopping Ozempic, Wegovy
Dr. Adrian Vale, MD — Internal Medicine · Board-Certified Obesity Medicine
Medically reviewed

Dr. Adrian Vale, MD

Internal Medicine · Board-Certified Obesity Medicine

Dr. Adrian Vale is a board-certified internal medicine physician with a clinical focus on obesity medicine and metabolic health. He reviews Shotlee guides and articles on GLP-1 medications, peptide therapy, and weight-management protocols for clinical accuracy.

View all articles reviewed by Dr. Adrian Vale, MD
Shotlee LogoShotlee

Your comprehensive health tracking companion. Track, analyze, and optimize your journey with advanced metrics and community support.

Product

  • Medication Trackers
  • Health Guides
  • Calculators
  • Compare Medications
  • Pricing

Resources

  • Health Blog
  • Support Center

Legal

  • Privacy Policy
  • Terms of Service
  • Community Guidelines
  • Refund Policy

© 2026 Shotlee. All rights reserved.

Made with for the community♥ for the community